Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model-Reference-Cited by-同舟云学术

Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model

Published:2016-11 Issue:5 Volume:48 Page:559-563
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Liu Xiaofen,Zhao Miao,Chen Yuancheng,Bian Xingchen,Li Yunfei,Shi Jun,Zhang Jing^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference20 articles.

1. Update on the epidemiology, treatment, and outcomes of carbapenem-resistant Acinetobacter infections;Kim;Chonnam Med J,2014

2. Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012);Farrell;Int J Antimicrob Agents,2014

3. CHINET 2014 surveillance of bacterial resistance in China;Hu;Chin J Infect Chemother,2015

4. Safety profile of meropenem;Linden;Drug Saf,2007

5. Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation;Frei;J Antimicrob Chemother,2008

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinations of Antibiotics Effective against Extensively- and Pandrug-Resistant Acinetobacter baumannii Patient Isolates;Microorganisms;2024-07-02

2. Treatment Outcomes and Associated Factors of Intravenous Colistin for Nosocomial Infections in Pediatric Patients: A Retrospective Study in a University Hospital in Thailand;Pediatric Infectious Disease Journal;2024-06-25

3. In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales;Frontiers in Pharmacology;2024-04-11

4. Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection;BMC Infectious Diseases;2023-10-20

5. Colistin resistance mechanisms in Gram-negative bacteria: a Focus onEscherichia coli;Letters in Applied Microbiology;2023-02